Advertisement
Clinical Services

Hollow Microstructured Transdermal System

May 1, 2014 2:23 pm | by Nikita Ernst, Associate Editor | 3M Drug Delivery Systems | Product Releases | Comments

Introducing a hollow microstructured transdermal system (hMTS) for pharmaceutical and biotech companies interested in conducting preclinical studies.

LISTED UNDER: Outsourcing | Clinical Services | CLINICAL TRIAL MATERIALS
Advertisement

Full Service CDMO

January 22, 2014 3:34 pm | Product Releases | Comments

Metrics Inc. is a full-service global CDMO. Our expertise includes FTIM formulations, Phases I-III CTM manufacturing and analytical support services leading to commercial manufacturing. 

LISTED UNDER: PHASE I | PHASE II | PHASE III

Bayer Outlines New Global R & D Structures; U.S. Pharma Sites and Future Headquarters

November 13, 2006 10:32 am | Pharmaceutical Processing | Product Releases | Comments

Bayer HealthCare has announced a structural realignment of its global pharmaceutical research and development organization. The company also outlined its future U.S. pharma site plan, and said that New Jersey will be home to its U.S. headquarters for pharmaceuticals.

LISTED UNDER: TOXICOLOGY SERVICES

Developing Your Science-Based Manufacturing Strategy

August 29, 2006 7:24 am | Pharmaceutical Processing | Product Releases | Comments

By: Bonnie Haferkamp Life Sciences Rockwell Automation This month marks the two-year anniversary of FDA’s release of its process analytical technology (PAT) guidance for industry.

LISTED UNDER: TOXICOLOGY SERVICES

FDA Appoints New Acting Director for National Center for Toxicological Research

January 18, 2006 5:36 am | Pharmaceutical Processing | Product Releases | Comments

The FDA has announced that William Slikker, Jr., Ph.D., will serve as the Acting Director of FDA's National Center for Toxicological Research (NCTR). Dr. Slikker replaces Dan Casciano, Ph.D.

LISTED UNDER: TOXICOLOGY SERVICES

FDA and Industry to Collaborate On Better Ways to Predict Liver Toxicity In Human Drug Trials - Part of FDA’s Critical Path Initiative to Modernizing Drug Development

November 16, 2005 10:15 am | Pharmaceutical Processing | Product Releases | Comments

The FDA and BG Medicine, a Massachusetts-based biotechnology research company, have agreed to collaborate on a project designed to overcome one of the obstacles to efficient development of safe drugs.

LISTED UNDER: TOXICOLOGY SERVICES

PharmaDiscovery 2005 Conference To Feature Leading Scientists

January 19, 2005 11:18 am | Pharmaceutical Processing | Product Releases | Comments

NORWALK, CT (January 18, 2005) – PharmaDiscovery 2005, produced by Elsevier’s Drug Discovery Today and Reed Exhibitions, announced a leading scientific line-up of speakers from the drug discovery community, at PharmaDiscovery on May 10-12, 2005, at the Washington, DC Convention Center.

LISTED UNDER: TOXICOLOGY SERVICES

Pharmaceutical Company Tightens Up Time to Market

November 9, 2004 7:01 am | Pharmaceutical Processing | Product Releases | Comments

Partnership with Professional Project Management Company Boosts Performance, Bottom-Line by $12 Million Time waits for no man or pharmaceutical company. This take on a familiar maxim is especially appropriate for drug makers.

LISTED UNDER: TOXICOLOGY SERVICES

Biological Safety Cabinet

March 10, 2003 9:34 am | Pharmaceutical Processing | Product Releases | Comments

ergonomically enhanced The SterilchemGARD® III Advance°, is an ergonomically enhanced biological safety cabinet designed for Class II, Type B2 installations where total-exhaust is required.

LISTED UNDER: Furniture/Accessories | TOXICOLOGY SERVICES
X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading